Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Circ Res ; 110(3): 496-507, 2012 Feb 03.
Article in English | MEDLINE | ID: mdl-22302756

ABSTRACT

Rarely a new research area has gotten such an overwhelming amount of attention as have microRNAs. Although several basic questions regarding their biological principles still remain to be answered, many specific characteristics of microRNAs in combination with compelling therapeutic efficacy data and a clear involvement in human disease have triggered the biotechnology community to start exploring the possibilities of viewing microRNAs as therapeutic entities. This review serves to provide some general insight into some of the current microRNAs targets, how one goes from the initial bench discovery to actually developing a therapeutically useful modality, and will briefly summarize the current patent landscape and the companies that have started to explore microRNAs as the next drug target.


Subject(s)
Biomedical Research/trends , MicroRNAs , Therapeutics/trends , Animals , Disease Models, Animal , Drug Industry , Humans , Patents as Topic
2.
Cell Mol Neurobiol ; 31(6): 909-20, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21538119

ABSTRACT

Electrophysiological and ultrastructural studies were performed on phrenic nerve-hemidiaphragm preparations isolated from wild-type and acetylcholinesterase (AChE) knockout (KO) mice to determine the compensatory mechanisms manifested by the neuromuscular junction to excess acetylcholine (ACh). The diaphragm was selected since it is the primary muscle of respiration, and it must adapt to allow for survival of the organism in the absence of AChE. Nerve-elicited muscle contractions, miniature endplate potentials (MEPPs) and evoked endplate potentials (EPPs) were recorded by conventional electrophysiological techniques from phrenic nerve-hemidiaphragm preparations isolated from 1.5- to 2-month-old wild-type (AChE(+/+)) or AChE KO (AChE(-/-)) mice. These recordings were chosen to provide a comprehensive assessment of functional alterations of the diaphragm muscle resulting from the absence of AChE. Tension measurements from AChE(-/-) mice revealed that the amplitude of twitch tensions was potentiated, but tetanic tensions underwent a use-dependent decline at frequencies below 70 Hz and above 100 Hz. MEPPs recorded from hemidiaphragms of AChE(-/-) mice showed a reduction in frequency and a prolongation in decay (37%) but no change in amplitude compared to values observed in age-matched wild-type littermates. In contrast, MEPPs recorded from hemidiaphragms of wild-type mice that were exposed for 30 min to the selective AChE inhibitor 5-bis(4-allyldimethyl-ammoniumphenyl)pentane-3-one (BW284C51) exhibited a pronounced increase in amplitude (42%) and a more marked prolongation in decay (76%). The difference between MEPP amplitudes and decays in AChE(-/-) hemidiaphragms and in wild-type hemidiaphragms treated with BW284C51 represents effective adaptation by the former to a high ACh environment. Electron microscopic examination revealed that diaphragm muscles of AChE(-/-) mice had smaller nerve terminals and diminished pre- and post-synaptic surface contacts relative to neuromuscular junctions of AChE(+/+) mice. The morphological changes are suggested to account, in part, for the ability of muscle from AChE(-/-) mice to function in the complete absence of AChE.


Subject(s)
Acetylcholinesterase/deficiency , Acetylcholinesterase/metabolism , Choline/metabolism , Synapses/physiology , Synapses/ultrastructure , Action Potentials/drug effects , Animals , Conotoxins/pharmacology , Diaphragm/drug effects , Diaphragm/innervation , Diaphragm/physiology , Evoked Potentials/drug effects , GPI-Linked Proteins/deficiency , GPI-Linked Proteins/metabolism , In Vitro Techniques , Mice , Mice, Knockout , Miniature Postsynaptic Potentials/drug effects , Muscle Contraction/drug effects , Muscle Tonus/drug effects , Synapses/drug effects , Synaptic Transmission/drug effects
3.
Nat Biotechnol ; 29(2): 129-33, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21301436

ABSTRACT

Strategies are needed for drafting miRNA patent applications, in light of the existing patent landscape and genomic patent strategies of the past decades.


Subject(s)
Biotechnology/legislation & jurisprudence , Drug Industry/legislation & jurisprudence , Intellectual Property , MicroRNAs , Patents as Topic , Animals , Disclosure , Expressed Sequence Tags , Humans
4.
Anal Biochem ; 366(2): 207-17, 2007 Jul 15.
Article in English | MEDLINE | ID: mdl-17548044

ABSTRACT

The potent botulinum neurotoxin inhibits neurotransmitter release at cholinergic nerve terminals, causing a descending flaccid paralysis characteristic of the disease botulism. The currently expanding medical use of the neurotoxin to treat several disorders, as well as the potential misuse of the neurotoxin as an agent in biowarfare, has made understanding of the nature of the toxin's catalytic activity and development of inhibitors critical. To study the catalytic activity of botulinum neurotoxin more thoroughly and characterize potential inhibitors, we have developed a capillary electrophoresis method to measure catalytic activity of different serotypes of botulinum neurotoxin using peptides derived from the native substrates. This assay requires only a minute amount of sample (25 nl), is relatively rapid (15 min/sample), and allows the determination of enzyme kinetic constants for a more sophisticated characterization of inhibitors and neurotoxin catalytic activity. Using this method, we can measure activity of five of the seven serotypes of botulinum neurotoxin (A, B, E, F, and G) with two peptide substrates. Botulinum neurotoxin serotypes C and D did not cleave our peptides, lending insight into potential substrate requirements among the serotypes.


Subject(s)
Botulinum Toxins/metabolism , Electrophoresis, Capillary/methods , Amino Acid Sequence , Botulinum Toxins/chemistry , Botulinum Toxins/genetics , Catalysis , Kinetics , Molecular Sequence Data , Oligopeptides/chemistry , Oligopeptides/metabolism , Reproducibility of Results
5.
Muscle Nerve ; 30(3): 317-27, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15318343

ABSTRACT

Nerve-evoked contractions were studied in vitro in phrenic nerve-hemidiaphragm preparations from strain 129X1 acetylcholinesterase knockout (AChE-/-) mice and their wild-type littermates (AChE+/+). The AChE-/- mice fail to express AChE but have normal levels of butyrylcholinesterase (BChE) and can survive into adulthood. Twitch tensions elicited in diaphragms of AChE-/- mice by single supramaximal stimuli had larger amplitudes and slower rise and decay times than did those in wild-type animals. In AChE-/- preparations, repetitive stimulation at frequencies of 20 and 50 Hz and at 200 and 400 Hz produced decremental muscle tensions; however, stimulation at 70 and 100 Hz resulted in little or no loss of tension during trains. Muscles from AChE+/+ mice maintained tension at all frequencies examined but exhibited tetanic fade after exposure to the selective AChE inhibitor 1,5-bis(4-allyldimethyl-ammoniumphenyl)pentane-3-one (BW 284C51). The ability of diaphragm muscles from AChE-/- mice to maintain tension at 70 and 100 Hz suggests a partial compensation for impairment of acetylcholine (ACh) hydrolysis. Three mechanisms--including a reliance on BChE activity for termination of ACh action, downregulation of nicotinic acetylcholine receptors (nAChRs), and morphological remodeling of the endplate region--were identified. Studies of neuromuscular transmission in this model system provide an excellent opportunity to evaluate the role of AChE without complications arising from use of inhibitors.


Subject(s)
Acetylcholinesterase/deficiency , Butyrylcholinesterase/metabolism , Diaphragm/enzymology , Muscle Contraction/physiology , Receptors, Nicotinic/metabolism , Acetylcholine/metabolism , Acetylcholinesterase/genetics , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Butyrylcholinesterase/physiology , Diaphragm/drug effects , Diaphragm/ultrastructure , Enzyme Activation/genetics , Female , Hydrolysis , Male , Mice , Mice, Knockout , Muscle Contraction/drug effects , Receptors, Nicotinic/ultrastructure
6.
Trends Neurosci ; 26(11): 625-30, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14585603

ABSTRACT

Tyrosine kinases were first characterized in terms of their function during development. Over the past decade, it has become clear that tyrosine phosphorylation also plays an important role in the adult mammalian nervous system. This article reviews three different families of tyrosine kinase signaling cascades: the Trk receptor tyrosine kinases, the Src family of non-receptor tyrosine kinases and the Eph receptor tyrosine kinases. Each of these cascades has been implicated in both adult synaptic plasticity and memory formation. Evidence from invertebrate systems also demonstrates a role for tyrosine kinase signaling in the induction of long-term memory, suggesting that molecular mechanisms of memory formation are conserved across species.


Subject(s)
Learning/physiology , Memory/physiology , Neuronal Plasticity/physiology , Receptor Protein-Tyrosine Kinases/physiology , Signal Transduction/physiology , Synaptic Transmission/physiology , src-Family Kinases/physiology , Animals , Invertebrates , Vertebrates
7.
Neuron ; 37(3): 473-84, 2003 Feb 06.
Article in English | MEDLINE | ID: mdl-12575954

ABSTRACT

Tyrosine kinases have been implicated in cellular processes thought to underlie learning and memory. Here we show that tyrosine kinases play a direct role in long-term synaptic facilitation (LTF) and long-term memory (LTM) for sensitization in Aplysia. Tyrosine kinase activity is required for serotonin-induced LTF of sensorimotor (SN-MN) synapses, and enhancement of endogenous tyrosine kinase activity facilitates the induction of LTF. These effects are mediated, at least in part, through mitogen-activated protein kinase (MAPK) activation and are blocked by transcriptional and translational inhibitors. Moreover, brain-derived neurotrophic factor (BDNF) also enhances the induction of LTF in a MAPK-dependent fashion. Finally, activation of endogenous tyrosine kinases enhances the induction of long-term memory for sensitization, and this enhancement also requires MAPK activation. Thus, tyrosine kinases, acting through MAPK, play a pivotal role in LTF and LTM formation.


Subject(s)
Long-Term Potentiation/physiology , MAP Kinase Signaling System/physiology , Memory/physiology , Synaptic Transmission/physiology , Animals , Aplysia , Brain-Derived Neurotrophic Factor/pharmacology , Dactinomycin/pharmacology , Enzyme Activation/physiology , Long-Term Potentiation/drug effects , Mitogen-Activated Protein Kinases/metabolism , Nucleic Acid Synthesis Inhibitors/pharmacology , Protein Biosynthesis/physiology , Protein-Tyrosine Kinases/metabolism , Serotonin/pharmacology , Synaptic Transmission/drug effects , Transcription, Genetic/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...